{"reporting_entity_name": "John Hopkins Health Plans","reporting_entity_type": "Commercial","last_updated_on": "2026-10-15","version": "2.0","provider_references": [                                                                                                                                                                   
{"provider_group_id":492005747,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1003047614,1003096132,1003318338,1003323924,1013071133,1013203330,1013581958,1023615002,1033305958,1033967138,1043373301,1053163014,1053238741,1053923888,1063757870,1073271169,1073389045,1083006480,1083026769,1083182752,1104306281,1114969961,1124183033,1134282320,1134283674,1134434939,1134577737,1134701766,1134887979,1144606641,1144853052,1144945841,1154063972,1154734002,1154778124,1164007365,1164584884,1164585428,1164838397,1174356364,1174885743,1184132979,1184173486,1194873968,1194884262,1205054400,1205974888,1205999406,1215090550,1215230362,1215450754,1235249962,1235281148,1235293929,1235531757,1235554064,1235821265,1235855958,1245202449,1255107892,1255452637,1265803027,1275040289,1275364846,1275696221,1285181792,1285473595,1285635128,1285796995,1295252393,1316000680,1316495062,1326101056,1326101510,1326285222,1326382409,1326504846,1326587650,1336076595,1336201060,1336378389,1346628716,1346667318,1356099238,1356830228,1366076218,1366589699,1376053116,1376108514,1376193078,1376606632,1376885863,1386536969,1396156907,1407092182,1417010786,1427286160,1427519719,1427746544,1437213691,1437606621,1447267620,1447600754,1447813068,1447884515,1477096758,1477288249,1477289668,1487800827,1487893038,1508101320,1508271966,1508618711,1508645185,1518387729,1518812866,1528061827,1528547189,1528609781,1538221254,1538223433,1538435037,1548675291,1558423285,1558424713,1558617563,1558676577,1558678250,1558885780,1568133155,1568619674,1568735850,1568911071,1568995702,1578614822,1578996278,1588718753,1598626038,1598703068,1598828220,1609111376,1609111418,1609328715,1609938315,1609939339,1619012374,1629485776,1639347453,1639353097,1639413685,1639456247,1639555287,1649415092,1649826330,1659050581,1659169969,1659744324,1659766897,1659795391,1669590642,1669814257,1669895694,1679069876,1679722185,1679818348,1689041493,1689154205,1689803629,1689983124,1699089706,1699141341,1699829416,1699838573,1700510104,1710156625,1710533245,1710555024,1710615216,1710623483,1720141005,1720141682,1720409097,1720474125,1720483035,1720718273,1720805385,1730242983,1730351719,1730430430,1730504713,1740078609,1740343011,1740343417,1740791102,1750511606,1760537435,1760613467,1760737548,1770890477,1770901258,1780026187,1780747725,1780990150,1790934040,1801036843,1801205034,1801266127,1801420781,1811015779,1811260052,1811595390,1811639206,1811729445,1821071713,1821150558,1821263039,1821490350,1821789025,1831495191,1841353034,1851475693,1851706675,1851886709,1861759664,1861780504,1871858738,1881927093,1891240735,1902031230,1902158355,1902403892,1902433618,1902799307,1912006313,1912284522,1912289539,1912363391,1912561499,1912961194,1922161207,1922161694,1922395136,1922837368,1932577657,1932838422,1942082516,1942199880,1942456546,1952085177,1952301772,1952464687,1962062836,1972665602,1972884781,1972899763,1972906980,1972926335,1982609541,1982767174,1992271258,1992868624],"tin":{"type":"ein","value":"521369749","business_name":"NATIONAL REHAB HOSP INC"}}]},
{"provider_group_id":492005748,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1700510104],"tin":{"type":"ein","value":"522310902","business_name":"NRH REHAB AT OLNEY"}}]}
], "in_network" : [
{"negotiation_arrangement":"ffs","name":"Medical Rehab Day Program - Full Day","billing_code_type":"RC","billing_code_type_version":"2025","billing_code":"0932","description":"Medical Rehab Day Program - Full Day","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"per diem","negotiated_rate":1000.0,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0249","description":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":529.99,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Antibody testing for a public health related pathogen, including coronavirus.","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D0605","description":"Antibody testing for a public health related pathogen, including coronavirus.","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":57.84,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); screen","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86408","description":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); screen","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.58,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"CPT-87812","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"87812","description":"CPT-87812","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":87.74,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"K1034","description":"Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Injection, remdesivir, 1 mg","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"J0248","description":"Injection, remdesivir, 1 mg","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":8.26,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 3 mcg/0.23 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91318","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 3 mcg/0.23 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":77.12,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosag","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91315","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosag","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0141A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by bulk acoustic wave biosensor immunoassay, severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0408U","description":"Infectious agent antigen detection by bulk acoustic wave biosensor immunoassay, severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":16.53,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 15 minutes","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"99401","description":"Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 15 minutes","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":44.77,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0231","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0231","description":"HCPCS-M0231","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"U0001","description":"Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus type","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87636","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus type","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0142A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) antibody, quantitative","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86413","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) antibody, quantitative","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0232","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0232","description":"HCPCS-M0232","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0235","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0235","description":"HCPCS-M0235","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90613","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90613","description":"CPT-90613","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0121A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0233","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0233","description":"HCPCS-M0233","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 1","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1701","description":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 1","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patients home; reported only once per individual home per date of service when such v","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0201","description":"Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patients home; reported only once per individual home per date of service when such v","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":45.25,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0236","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0236","description":"HCPCS-M0236","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"U0002","description":"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0237","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0237","description":"HCPCS-M0237","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), includes titer(s), when performed","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0224U","description":"Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), includes titer(s), when performed","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"distant site telehealth services","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"G2025","description":"distant site telehealth services","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":108.71,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87426","description":"severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":41.71,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary’s home that has been made provider","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0248","description":"Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary’s home that has been made provider","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 10 mcg/0.23 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91319","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 10 mcg/0.23 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":111.74,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0225U","description":"Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosa","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91313","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosa","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0171A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); titer","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86409","description":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); titer","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":93.64,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preserva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91304","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preserva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":226.24,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dos","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91314","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dos","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunoch","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87428","description":"Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunoch","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":82.63,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86328","description":"Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":53.51,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0223U","description":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87637","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 2","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1704","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 2","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"CPT-91323","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"91323","description":"CPT-91323","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":238.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 50 mcg/0.5 mL dosage, for intramuscular use","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91322","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 50 mcg/0.5 mL dosage, for intramuscular use","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":190.44,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 25 mcg/0.25 mL dosage, for intramuscular use","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91321","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 25 mcg/0.25 mL dosage, for intramuscular use","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":173.12,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; ; respirator","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87633","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; ; respirator","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0235","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0235","description":"HCPCS-Q0235","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunoassay for infectious agent antibody(ies), qualitative or semi quantitative, single-step method (eg, reagent strip);","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86318","description":"Immunoassay for infectious agent antibody(ies), qualitative or semi quantitative, single-step method (eg, reagent strip);","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":21.25,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syn","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87631","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syn","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91317","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require suppleme","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"Q0249","description":"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require suppleme","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":9.05,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; respiratory","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87632","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; respiratory","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":256.93,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 1","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1703","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 1","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0151A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosa","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91316","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosa","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90612","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90612","description":"CPT-90612","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0202U","description":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), ELISA, plasma, serum","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0226U","description":"Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), ELISA, plasma, serum","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.97,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosag","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91312","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosag","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe techniq","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87635","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe techniq","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0238","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0238","description":"HCPCS-Q0238","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":6.69,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0238","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0238","description":"HCPCS-M0238","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91320","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":198.31,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disea","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87811","description":"Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disea","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":48.79,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0250","description":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":529.99,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 3","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1708","description":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 3","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0234","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0234","description":"HCPCS-Q0234","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent genotype analysis by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identi","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87913","description":"Infectious agent genotype analysis by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":303.36,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 3","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1710","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 3","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0172A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0234","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0234","description":"HCPCS-M0234","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Publ","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"99072","description":"Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Publ","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0237","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0237","description":"HCPCS-Q0237","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":5.9,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) (coronavirus disease [COVID-19]) vaccine, single dose","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"90480","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) (coronavirus disease [COVID-19]) vaccine, single dose","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":26.9,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90481","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90481","description":"CPT-90481","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86769","description":"Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.58,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 50mcg/0.25mL IM DOSE BOOSTER","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1711","description":"SARSCOV2 COVID-19 VAC mRNA 50mcg/0.25mL IM DOSE BOOSTER","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Molecular testing for a public health related pathogen, including coronavirus","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D0606","description":"Molecular testing for a public health related pathogen, including coronavirus","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":115.28,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preserva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91304","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preserva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":226.24,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Publ","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"99072","description":"Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Publ","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"CPT-91323","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"91323","description":"CPT-91323","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":238.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), ELISA, plasma, serum","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0226U","description":"Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), ELISA, plasma, serum","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.97,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0250","description":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":529.99,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosa","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91313","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosa","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Injection, remdesivir, 1 mg","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"J0248","description":"Injection, remdesivir, 1 mg","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":8.26,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); screen","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86408","description":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); screen","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.58,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; ; respirator","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87633","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; ; respirator","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 3","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1708","description":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 3","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent genotype analysis by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identi","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87913","description":"Infectious agent genotype analysis by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":303.36,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0249","description":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":529.99,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dos","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91314","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dos","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"U0001","description":"Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0234","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0234","description":"HCPCS-Q0234","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0234","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0234","description":"HCPCS-M0234","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90481","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90481","description":"CPT-90481","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0141A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90613","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90613","description":"CPT-90613","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0142A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Antibody testing for a public health related pathogen, including coronavirus.","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D0605","description":"Antibody testing for a public health related pathogen, including coronavirus.","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":57.84,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87637","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0151A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syn","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87631","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syn","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); titer","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86409","description":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); titer","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":93.64,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 50mcg/0.25mL IM DOSE BOOSTER","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1711","description":"SARSCOV2 COVID-19 VAC mRNA 50mcg/0.25mL IM DOSE BOOSTER","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0235","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0235","description":"HCPCS-Q0235","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0225U","description":"Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91317","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90612","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90612","description":"CPT-90612","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0171A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe techniq","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87635","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe techniq","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87426","description":"severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":41.71,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86328","description":"Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":53.51,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91320","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":198.31,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 10 mcg/0.23 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91319","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 10 mcg/0.23 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":111.74,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"distant site telehealth services","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"G2025","description":"distant site telehealth services","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":108.71,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0235","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0235","description":"HCPCS-M0235","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0232","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0232","description":"HCPCS-M0232","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patients home; reported only once per individual home per date of service when such v","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0201","description":"Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patients home; reported only once per individual home per date of service when such v","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":45.25,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), includes titer(s), when performed","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0224U","description":"Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), includes titer(s), when performed","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0237","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0237","description":"HCPCS-M0237","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0233","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0233","description":"HCPCS-M0233","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require suppleme","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"Q0249","description":"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require suppleme","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":9.05,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) (coronavirus disease [COVID-19]) vaccine, single dose","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"90480","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) (coronavirus disease [COVID-19]) vaccine, single dose","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":26.9,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0202U","description":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus type","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87636","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus type","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0236","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0236","description":"HCPCS-M0236","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 1","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1701","description":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 1","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) antibody, quantitative","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86413","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) antibody, quantitative","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 25 mcg/0.25 mL dosage, for intramuscular use","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91321","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 25 mcg/0.25 mL dosage, for intramuscular use","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":173.12,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunoch","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87428","description":"Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunoch","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":82.63,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disea","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87811","description":"Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disea","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":48.79,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; respiratory","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87632","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; respiratory","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":256.93,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0172A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary’s home that has been made provider","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0248","description":"Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary’s home that has been made provider","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 15 minutes","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"99401","description":"Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 15 minutes","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":44.77,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0238","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0238","description":"HCPCS-M0238","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 50 mcg/0.5 mL dosage, for intramuscular use","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91322","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 50 mcg/0.5 mL dosage, for intramuscular use","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":190.44,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"CPT-87812","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"87812","description":"CPT-87812","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":87.74,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0237","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0237","description":"HCPCS-Q0237","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":5.9,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0223U","description":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 1","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1703","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 1","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosa","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91316","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosa","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0238","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0238","description":"HCPCS-Q0238","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":6.69,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosag","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91315","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosag","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by bulk acoustic wave biosensor immunoassay, severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0408U","description":"Infectious agent antigen detection by bulk acoustic wave biosensor immunoassay, severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":16.53,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0231","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0231","description":"HCPCS-M0231","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86769","description":"Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.58,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosag","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91312","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosag","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunoassay for infectious agent antibody(ies), qualitative or semi quantitative, single-step method (eg, reagent strip);","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86318","description":"Immunoassay for infectious agent antibody(ies), qualitative or semi quantitative, single-step method (eg, reagent strip);","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":21.25,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 3 mcg/0.23 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91318","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 3 mcg/0.23 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":77.12,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"U0002","description":"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 3","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1710","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 3","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"K1034","description":"Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Molecular testing for a public health related pathogen, including coronavirus","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D0606","description":"Molecular testing for a public health related pathogen, including coronavirus","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":115.28,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 2","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1704","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 2","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0121A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[492005747]}]}]}